Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV

Journal of Neurology

Volumn 256, Issue 6, 2009, Pages 948-953

  Obermann, Mark ^a   Kuper M ^a   Kastrup, O ^a   Yaldizli, O ^a   Esser, S ^a   Thiermann, J ^a   Koutsilieri, E ^b   Arendt, G ^c   Diener, H C ^a   Maschke, M ^a,d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Bruederkrankenhaus Trier ^*  (Germany)

Author keywords

AIDS; Dopamine; HIV dementia; Substantia nigra echogenicity; Transcranial sonography

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RATING SCALE; SUBSTANTIA NIGRA; TASK PERFORMANCE;

3,4-DIHYDROXYPHENYLACETIC ACID; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; FEMALE; HIV INFECTIONS; HOMOVANILLIC ACID; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SPINAL PUNCTURE; SUBSTANTIA NIGRA;

EID: 67650447438     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5052-3     Document Type: Article

References (28)

1. G Arendt T Nolting C Frisch IW Husstedt N Gregor E Koutsilieri M Maschke A Angerer M Obermann E Neuen-Jacob O Adams S Loeffert P Riederer V ter Meulen S Sopper 2007 Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease J Neurovirol 13 225 232 (Pubitemid 47050648)
2. G Bagetta MT Corasaniti L Aloe L Berliocchi N Costa A Finazzi-Agro G Nistico 1996 Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat Proc Natl Acad Sci USA 93 928 933 (Pubitemid 26041197)
3. G Becker J Seufert U Bogdahn H Reichmann K Reiners 1995 Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography Neurology 45 182 184
4. S Behnke D Berg M Naumann G Becker 2005 Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound J Neurol Neurosurg Psychiatry 76 423 425 (Pubitemid 40299138)
5. S Behnke KL Double S Duma GA Broe V Guenther G Becker GM Halliday 2007 Substantia nigra echomorphology in the healthy very old: correlation with motor slowing Neuroimage 34 1054 1059 (Pubitemid 46075195)
6. BA Bennett DE Rusyniak CK Hollingsworth 1995 HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures Brain Res 705 168 176 (Pubitemid 26038768)
7. D Berg G Becker B Zeiler O Tucha E Hofmann M Preier P Benz W Jost K Reiners KW Lange 1999 Vulnerability of the nigrostriatal system as detected by transcranial ultrasound Neurology 53 1026 1031 (Pubitemid 29442119)
8. D Berg B Jabs U Merschdorf H Beckmann G Becker 2001 Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy Biol Psychiatry 50 463 467 (Pubitemid 32885597)
9. D Berg C Siefker G Becker 2001 Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings J Neurol 248 684 689 (Pubitemid 32695865)
10. D Berg B Merz K Reiners M Naumann G Becker 2005 Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease Mov Disord 20 383 385 (Pubitemid 40613305)
11. JR Berger G Arendt 2000 HIV dementia: the role of the basal ganglia and dopaminergic systems J Psychopharmacol 14 214 221 (Pubitemid 30847801)
12. JR Berger M Kumar A Kumar JB Fernandez B Levin 1994 Cerebrospinal fluid dopamine in HIV-1 infection AIDS 8 67 71 (Pubitemid 24094090)
13. M Biard-Piechaczyk V Robert-Hebmann V Richard J Roland RA Hipskind C Devaux 2000 Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120) Virology 268 329 344 (Pubitemid 30159982)
14. A di Rocco T Bottiglieri D Dorfman P Werner C Morrison D Simpson 2000 Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients Clin Neuropharmacol 23 190 194
15. E Hriso T Kuhn JC Masdeu M Grundman 1991 Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy Am J Psychiatry 148 1558 1561
16. K Itoh P Mehraein S Weis 2000 Neuronal damage of the substantia nigra in HIV-1 infected brains Acta Neuropathol 99 376 384 (Pubitemid 30179576)
17. E Koutsilieri ME Gotz S Sopper C Stahl-Hennig M Czub V ter Meulen P Riederer 1997 Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta) Neuroreport 8 3833 3836 (Pubitemid 28004884)
18. II Kruman A Nath MP Mattson 1998 HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress Exp Neurol 154 276 288 (Pubitemid 29044201)
19. M Larsson L Hagberg A Forsman G Norkrans 1991 Cerebrospinal fluid catecholamine metabolites in HIV-infected patients J Neurosci Res 28 406 409
20. O Meucci A Fatatis AA Simen TJ Bushell PW Gray RJ Miller 1998 Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity Proc Natl Acad Sci USA 95 14500 14505 (Pubitemid 28549396)
21. A Nath C Anderson M Jones W Maragos R Booze C Mactutus J Bell KF Hauser M Mattson 2000 Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia J Psychopharmacol 14 222 227 (Pubitemid 30847802)
22. A Nath K Psooy C Martin B Knudsen DS Magnuson N Haughey JD Geiger 1996 Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic J Virol 70 1475 1480 (Pubitemid 26062905)
23. T Postert J Eyding D Berg H Przuntek G Becker M Finger L Schols 2004 Transcranial sonography in spinocerebellar ataxia type 3 J Neural Transm Suppl 68 123 133 (Pubitemid 39215446)
24. T Postert B Lack W Kuhn M Jergas J Andrich B Braun H Przuntek R Sprengelmeyer M Agelink T Buttner 1999 Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography J Neurol Neurosurg Psychiatry 67 457 462 (Pubitemid 29438200)
25. MG Reyes F Faraldi CS Senseng C Flowers R Fariello 1991 Nigral degeneration in acquired immune deficiency syndrome (AIDS) Acta Neuropathol 82 39 44
26. C Schmidauer M Sojer K Seppi H Stockner B Hogl B Biedermann E Brandauer CM Peralta GK Wenning W Poewe 2005 Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome Ann Neurol 58 630 634 (Pubitemid 41377229)
27. J Spiegel D Hellwig MO Mollers S Behnke W Jost K Fassbender S Samnick U Dillmann G Becker CM Kirsch 2006 Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease Brain 129 1188 1193
28. U Walter J Hoeppner L Prudente-Morrissey S Horowski SC Herpertz R Benecke 2007 Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders Brain 130 1799 1807 (Pubitemid 47343787)